Wei Zhuang

19PUBLICATIONS
25CO-AUTHORS
AutoimmunityNeonatologyGene and molecular therapyMolecular targetsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 05, 2026
Profiling Immune-Related Adverse Events Associated with Imatinib: A Two-Decade Real-World Safety Study Based on FDA Adverse Event Reporting System.

|Apr 10, 2026
Incidence, risk factors, and prediction model of piperacillin/tazobactam-associated hypokalemia in neonates.

Jun Wan, Shiteng Lin, Wei Zhuang

|Mar 28, 2026
Genetic Variations in the M6A Modification Pathway as Potential Predictors of Imatinib Secondary Resistance in Gastrointestinal Stromal Tumors.

Baijun Zhou, Zhenchong Chen, Gengyi Zhang

|Nov 05, 2025
Genetic and pharmacokinetic factors associated with imatinib-induced toxicities in gastrointestinal stromal tumors.

Wei Zhuang, Yi Zeng, Xinping Lin

|Jul 02, 2025
ETV1 genetic polymorphisms as a candidate prognosis biomarker of Gastrointestinal stromal tumor.

Wei Zhuang, Minju Jo, Haibo Qiu

|Jul 02, 2025
Evaluating safety risks of ischaemic colitis with taxanes: a disproportionality analysis based on FDA adverse event Reporting system.

Yufang Liao, Yanbin Zeng, Xiaorong Su

Pageof 4

Frequent Collaborators

4 joint publications

Min Huang

3 joint publications

Xueding Wang

2 joint publications

Wanlong Lin

1 joint publications

Shaoxing Guan